How to become more resilient, according to the research

Mount Sinai Creates Transformational New Model of Behavioral Health Care With New State-of-the-Art $140 Million Center

Discovery’s Science Channel Partners With Mount Sinai Health System to Create Digital Series Featuring Innovations in Science and Medicine

"Dennis Charney, MD - The Hope of Ketamine for Depression" - Kevin Kunzmann

"Approved Nasal Spray Gives Hope to Patients with Severe Depression" - Delthia Ricks

"In Biggest Advance for Depression in Years, FDA Approves Novel Treatment for Hardest Cases" - Carolyn Y. Johnson and Laurie McGinley

Icahn School of Medicine Dean Dennis Charney, MD, Co-Invented a Patented Method of Treating Patients with Treatment-Resistant Depression Which Is Part of the Drug Application for Janssen’s Newly Approved SPRAVATO™ (esketamine) CIII Nasal Spray

"FDA Expected To Approve Esketamine Nasal Spray For Depression" - Jon Hamilton

"FDA Could Approve Ketamine Nasal Spray as Depression Treatment" - Jonathan Lapook

"Ketamine Could Be The Key To Reversing America’s Rising Suicide Rate" - Cynthia Koons and Robert Langreth

"Positive Aging Through Resilience" - Claire Halverson